Skip to content

Cambrex Announces Stability Storage Expansions in Ireland and Belgium

By asianet

Cambrex today announced the expansion of their stability storage business, Q1 Scientific, which offers environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries. Q1 Scientific will open a new 20,000-square-foot cGMP facility in Belgium and add an additional 10,000 square feet at their existing facility in Waterford, Ireland. The expansions will … Continued

Hayashibara Brings Back “Trehalose Symposium” to Reveal Its Game-changing Versatilities in Human Biochemistry

By asianet

Hayashibara Co., Ltd., a member of Nagase Group and headquartered in Okayama City, western Japan, hosted the 24th Trehalose Symposium, with the support of the Japanese Society of Applied Glycoscience, on September 8, 2022. Photo: https://kyodonewsprwire.jp/prwfile/release/M104815/202209297422/_prw_PI1fl_JX2ftzQv.png This highly specialized academic event returned to Tokyo after a three-year hiatus, engaging 231 attendees in person and online … Continued

ABILITY DIABETES GLOBAL – A Landmark RCT in the field of PCI for patients with DM, completes Enrolment

By asianet

ABILITY DIABETES-GLOBAL [https://www.conceptmedical.com/clinical-program/ability-diabetes-global/](ADG), is the World’s largest Randomized Controlled Trial (RCT) for patients with DM (Diabetes Mellitus), comparing head-to-head the Sirolimus eluting stent , Abluminus DES+ (Concept Medical Inc.[https://www.conceptmedical.com/]) with the XIENCE family of DES (Abbott Cardiovascular). Diabetes has been the Achilles heel for any vascular interventional procedures and there is a clinical need for … Continued

Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib

By asianet

The FDA has assigned a PDUFA goal date of March 29, 2023 for the NDA submission based on randomized-controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces that the US Food and Drug Administration (FDA) … Continued

TargEDys and Inoliva announce they have entered a distribution partnership to bring Satylia(R) to Turkey

By asianet

TargEDys and Inoliva, an affiliate of Abdi Ibrahim, have signed an exclusive marketing and distribution agreement to bring Satylia, a food supplement based on the next-generation probiotic Hafnia alvei HA4597, to the Turkish market. Satylia, also called EnteroSatys in other markets, is a precision probiotic with a characterized mechanism of action at molecular level: it … Continued

AAHRPP Accredits Five More Research Organizations, Including First in Japan

By asianet

The Association for the Accreditation ( https://c212.net/c/link/?t=0&l=en&o=3657696-1&h=2135994626&u=https%3A%2F%2Fwww.aahrpp.org%2F&a=Accreditation ) of Human Research Protection Programs has accredited five more research organizations, including its first organization in Japan, two public research universities, a children’s hospital and an acute-care hospital. Logo – https://mma.prnewswire.com/media/224365/aahrpp_logo.jpg At its September meeting, AAHRPP’s Council on Accreditation awarded full accreditation to: — Adventist Health Glendale, … Continued

Ivory Dentin Graft(TM), the First and Only Dentin Graft, Receives CE Mark

By asianet

– Ivory Dentin Graft creates a new dentin category of graft substitutes for repair and augmentation of bone defects. Developed by Ivory Graft Ltd.[]https://ivorygraft.com/, the Ivory Dentin Graft(TM) is a new dentin graft. This graft material has been tailored for use in dental procedures based on the advantages of autologous dentin grafts, documented and proven … Continued

The 6th China Health and Senior Care Conference held in southwest Chinese city Shizhu

By asianet

On August 30th, the 6th China Health and Senior Care Conference was held in Huangshui Town, a summer resort in Shizhu Tujia Autonomous County, southwest China’s Chongqing Municipality. Hosted by the Revolutionary Committee of the Chinese Kuomintang and the Chongqing Municipal Political Consultative Conference, the conference sought to promote the development of health care industry … Continued

Mediaseek’s Proprietary Neurofeedback Engine “Alpha Switch” and Its Smartphone Application Mentioned in International Journal

By asianet

– Engine and App Used in Research Paper on Chronic Low Back Pain Treatment at Pain Center of Chiba University Hospital Published in “Scientific Reports” – Mediaseek, Inc. (hereinafter referred to as “Mediaseek”) based in Tokyo is pleased to announce that a research article on the treatment of nonspecific chronic low back pain, conducted by … Continued